Back to search

Article

Inadvertent Transfer of Murine VL30 Retrotransposons to CAR-T Cells

2022-02-01

Abstract excerpt

For more than a decade genetically engineered autologous T-cells have been successfully employed as immunotherapy drugs for patients with incurable blood cancers. The active component in some of these game-changing medicines are autologous T-cells that express viral vector-delivered chimeric antigen receptors (CARs), which specifically target proteins that are preferentially expressed on cancer cells. Some of thes...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d18cc253-b6dd-5f6e-b3b8-e2e30be921a2
DOI
10.1101/2022.02.01.478686
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Inadvertent Transfer of Murine VL30 Retrotransposons to CAR-T CellsDOI 10.1101/2022.02.01.478686
Select a neighboring publication to make it the new centre.